The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of KYTHERA Biopharmaceuticals, Inc. (NASDAQGS: KYTH) ("KYTHERA" or "the Company") in connection with the sale of the Company to Allergan plc (NYSE: AGN).

Click here to learn about the case: There is no cost or obligation to you.

Under the terms of the transaction, KYTHERA shareholders will receive approximately $75.00 in cash and stock for each share of KYTHERA stock they own. The investigation concerns whether the Board of KYTHERA breached their fiduciary duties to shareholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Allergan is underpaying for KYTHERA shares.

If you own common stock in KYTHERA and wish to obtain additional information, please contact Vincent Wong, Esq. either via email, by telephone at 212.425.1140, or visit

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on

Copyright Business Wire 2010